Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Children Chai Fang Jie Du Granule is a Traditional Chinese Medicine (TCM) formulation developed by Guang'anmen Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed for pediatric use to treat early-stage influenza, particularly cases characterized by the TCM syndrome of "wind-heat invading the lung." The granule is typically evaluated as an adjunctive therapy to standard antiviral treatments like oseltamivir phosphate to improve clinical outcomes and safety in children aged 3 to 16 years. As a TCM product, it is composed of multiple botanical extracts intended to clear heat and detoxify the respiratory system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Children Chai Fang Jie Du Granule.